For emerging biotech firms, obtaining capital can be a major hurdle. Hiring a full-time Chief Financial Executive is frequently excessively expensive, especially when income are limited. A part-time CFO provides a https://sabrinammgf968871.blog5.net/92505775/fractional-cfo-a-biotech-funding-lifeline